Previous Close | 18.13 |
1-Year Change | 72.83% |
6-Months Change | 54.56% |
3-Months Change | 41.64% |
Moving Avg (50d) | 16.776 |
Moving Avg (200d) | 12.13 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 0.78B |
Beta (3-Years) | 1.3 |
Revenue Growth (ttm) | 13.66% |
Net Profit Margin (ttm) | -15.26% |
Return On Assets (ttm) | -11.94% |
EPS (ttm) | -0.56 |
PE Ratio (ttm) | -32.37 |
Dividend Yield | % |
Asset Description: | AxoGen, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Neutral |
Forecast Date: | 2025-02-10 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
18.493 | 19.036 | 19.399 | 19.943 | 20.849 | 21.756 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Health Care Technology |
Country: | United States |